{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T20:52:42Z","timestamp":1759179162241},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health SCCOR","doi-asserted-by":"publisher","award":["P50 HL081011"],"award-info":[{"award-number":["P50 HL081011"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.thromres.2014.04.023","type":"journal-article","created":{"date-parts":[[2014,4,28]],"date-time":"2014-04-28T21:17:18Z","timestamp":1398719838000},"page":"96-104","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Multi-parameter assessment of platelet inhibition and its stability during aspirin and clopidogrel therapy"],"prefix":"10.1016","volume":"134","author":[{"given":"A. Anil","family":"Timur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gurunathan","family":"Murugesan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Barnard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak L.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kandice","family":"Kottke-Marchant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2014.04.023_bb0005","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.avsg.2009.03.008","article-title":"Antiplatelet medications: Old and emerging therapies","volume":"24","author":"Stone","year":"2010","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.thromres.2014.04.023_bb0010","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11936-009-0003-y","article-title":"Selecting optimal antiplatelet therapy based on platelet function monitoring in patients with coronary artery disease","volume":"11","author":"Gurbel","year":"2009","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"10.1016\/j.thromres.2014.04.023_bb0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cpcardiol.2009.11.002","article-title":"Antiplatelet agents in acute coronary syndromes","volume":"35","author":"Sakhuja","year":"2010","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.thromres.2014.04.023_bb0020","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/ccd.22021","article-title":"Antiplatelet therapy in percutaneous coronary intervention: A critical review of the 2007 AHA\/ACC\/SCAI guidelines and beyond","volume":"74","author":"Cohen","year":"2009","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.thromres.2014.04.023_bb0025","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1093\/eurheartj\/ehp296","article-title":"P2Y(12) inhibitors: Differences in properties and mechanisms of action and potential consequences for clinical use","volume":"30","author":"Wallentin","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.thromres.2014.04.023_bb0030","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.amjcard.2009.03.022","article-title":"Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy","volume":"104","author":"Ben-Dor","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.thromres.2014.04.023_bb0035","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jacc.2005.08.058","article-title":"Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: The role of dual drug resistance","volume":"47","author":"Lev","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2014.04.023_bb0040","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jacc.2008.05.032","article-title":"Incidence and clinical impact of dual nonresponsiveness to aspirin and clopidogrel in patients with drug-eluting stents","volume":"52","author":"Gori","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2014.04.023_bb0045","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/bmj.39430.529549.BE","article-title":"Aspirin \"resistance\" and risk of cardiovascular morbidity: Systematic review and meta-analysis","volume":"336","author":"Krasopoulos","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2014.04.023_bb0050","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ahj.2010.06.004","article-title":"Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: Systematic review and meta-analysis","volume":"160","author":"Aradi","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.thromres.2014.04.023_bb0055","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2147\/VHRM.S9087","article-title":"Aspirin and clopidogrel resistance: Methodological challenges and opportunities","volume":"6","author":"Gasparyan","year":"2010","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.thromres.2014.04.023_bb0060","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.amjcard.2003.08.072","article-title":"Incidence of aspirin nonresponsiveness using the ultegra rapid platelet function assay-ASA","volume":"92","author":"Wang","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.thromres.2014.04.023_bb0065","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.amjcard.2004.11.045","article-title":"Aspirin resistance and a single gene","volume":"95","author":"Jefferson","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.thromres.2014.04.023_bb0070","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1751-553X.2012.01420.x","article-title":"P2RY1 and P2RY12 polymorphisms and on-aspirin platelet reactivity in patients with coronary artery disease","volume":"34","author":"Timur","year":"2012","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.thromres.2014.04.023_bb0075","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/CIRCULATIONAHA.108.812636","article-title":"Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: A 12-month follow-up","volume":"119","author":"Marcucci","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2014.04.023_bb0080","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jtcvs.2004.02.019","article-title":"Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting","volume":"128","author":"Chen","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.thromres.2014.04.023_bb0085","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jacc.2008.10.045","volume":"53","author":"Gurbel","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2014.04.023_bb0090","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.jacc.2007.12.044","article-title":"Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: A multicenter randomized prospective study","volume":"51","author":"Bonello","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2014.04.023_bb0095","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1161\/CIRCULATIONAHA.111.029165","article-title":"Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: A time-dependent analysis of the gauging responsiveness with a VerifyNow P2Y12 assay: Impact on thrombosis and safety (GRAVITAS) trial","volume":"124","author":"Price","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2014.04.023_bb0100","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1016\/j.jacc.2013.07.101","article-title":"Consensus and update on the definition of on-treatment platelet reactivity to ADP associated with ischemia and bleeding","volume":"62","author":"Tantry","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2014.04.023_bb0105","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.amjcard.2004.12.038","article-title":"Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarction","volume":"95","author":"Schwartz","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.thromres.2014.04.023_bb0110","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jvs.2010.08.029","article-title":"Variability and persistence of aspirin response in lower extremity peripheral arterial disease patients","volume":"53","author":"Saunders","year":"2011","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.thromres.2014.04.023_bb0115","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/09537100701771736","article-title":"Lack of reproducibility of assessment of aspirin responsiveness by optical aggregometry and two platelet function tests","volume":"19","author":"Harrison","year":"2008","journal-title":"Platelets"},{"key":"10.1016\/j.thromres.2014.04.023_bb0120","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0002-9149(03)00163-2","article-title":"Durability of platelet inhibition by clopidogrel","volume":"91","author":"Gurbel","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.thromres.2014.04.023_bb0125","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1160\/TH10-07-0440","article-title":"Stability of the high on-treatment platelet reactivity phenotype over time in clopidogrel-treated patients","volume":"105","author":"Jaitner","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.04.023_bb0130","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/eurheartj\/ehm232","article-title":"Laboratory detection of 'aspirin resistance': what test should we use (if any)?","volume":"28","author":"Marco","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.thromres.2014.04.023_bb0135","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1093\/eurheartj\/ehm226","article-title":"A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease","volume":"28","author":"Lordkipanidze","year":"2007","journal-title":"Eur Heart J"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384814002370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384814002370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T11:23:19Z","timestamp":1538652199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384814002370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0049384814002370"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2014.04.023","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multi-parameter assessment of platelet inhibition and its stability during aspirin and clopidogrel therapy","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2014.04.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}